- Associated Press - Friday, October 21, 2011

BRUSSELS (AP) - The European Union is investigating whether drug companies Novartis and Johnson & Johnson colluded to keep a generic painkiller out of the Dutch market, the bloc’s antitrust watchdog said Friday.

The European Commission is assessing whether contractual arrangements between the two companies “may have had the object or effect of hindering the entry on to the market of generic versions of Fentanyl.”

Fentanyl is a strong painkiller for chronic pain.

Novartis spokesman Eric Althoff confirmed the probe, but added “we don’t comment on ongoing procedures.” The Basel-based company reports its third-quarter results Tuesday.

The Commission said the investigation was triggered by its own inquiry into the ability of generics _ cheaper versions of medications that are no longer protected by patents _ to enter the market.

Copyright © 2018 The Washington Times, LLC.

The Washington Times Comment Policy

The Washington Times is switching its third-party commenting system from Disqus to Spot.IM. You will need to either create an account with Spot.im or if you wish to use your Disqus account look under the Conversation for the link "Have a Disqus Account?". Please read our Comment Policy before commenting.

 

Click to Read More

Click to Hide